TrialScience translational medicine2022

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.

William A Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.